Exendin‐4 enhances radiation response of prostate cancer
Authors:
- 15 July 2018
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 78 (15) , 1125-1133
Abstract
Background: Exendin‐4, one of the most widely used antidiabetic drugs, has recently been reported to have potential antitumor effects in cancers. Prostate cancer (PC) is one of the most common cancers in male patients with type 2 diabetes mellitus, and radiotherapy plays a vital role in the therapy of PC. Whether exendin‐4 has the potential to enhance PC response to ionizing radiation (IR) remains unknown. We aimed to explore whether exendin‐4 radiosensitizes PC cells.Methods: GLP‐1 receptor (GLP‐1R) expression in PC tissue samples and cell lines were analyzed, Human prostate cancer cells (PC3 and LNCap) were treated with IR and exendin‐4, and subjected to proliferation, clone formation, cell cycle, immunoblotting, and immunohistochemical analysis. An in situ prostate tumor of animal model was established.Results: We found that GLP‐1R was expressed in human PC tissues and cell lines. 1‐100 nM exendin‐4 promoted the anti‐proliferation effects of IR in vitro and in vivo, and enhanced radiation‐induced G2/M cycle arrest in PC cells in a dose‐dependent manner. Furthermore, Ex‐4 increased AMPK phosphorylation, decrease the levels of p‐mTOR, cyclin B, and p34cdc2.Conclusions: Our study suggested exendin‐4 radiosensitizes PC cells via activation of AMPK A and subsequent inhibition of p‐mTOR, cyclin B, and p34cdc2 activation.Keywords
Funding Information
- Natural Science Foundation of Jiangxi Province (20171BAB205017)
- National Natural Science Foundation of China (30960440)
This publication has 30 references indexed in Scilit:
- Effect of the GLP-1 Analog Exendin-4 and Oxaliplatin on Intrahepatic Cholangiocarcinoma Cell Line and Mouse ModelInternational Journal of Molecular Sciences, 2013
- Effects of GLP-1 on Forearm Vasodilator Function and Glucose Disposal During Hyperinsulinemia in the Metabolic SyndromeDiabetes Care, 2013
- Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cellsScientific Reports, 2012
- Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathwaysRadiation Oncology, 2011
- The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cellsBreast Cancer Research and Treatment, 2011
- Ionizing Radiation Activates AMP-Activated Kinase (AMPK): A Target for Radiosensitization of Human Cancer CellsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- The incretin system and its role in type 2 diabetes mellitusMolecular and Cellular Endocrinology, 2009
- Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical ConsiderationsThe Review of Diabetic Studies, 2009
- The Glucagon‐Like PeptidesAnnals of the New York Academy of Sciences, 2006
- Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful ReperfusionCirculation, 2004